Enterprise Products Partners LP EPD is currently considered undervalued, trading at a 10.73x trailing 12-month enterprise value to earnings before interest, taxes, depreciation and amortization ...
Steris said the trial against its Isomedix subsidiary was dismissed and will be rescheduled for a later date. The Irish medical-device company said the case, which began on Dec. 4, was declared a ...
DUBLIN, IRELAND, Jan. 21, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that a jury trial that had been ongoing since December 4, 2024, against Isomedix ...